| Bioactivity | AP30663 is a KCa2 channel inhibitor that can be used for the study of atrial fibrillation[1]. |
| Name | AP30663 |
| Formula | C20H18F3N5O |
| Molar Mass | 401.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Holst A G, Tomcsányi J, Vestbjerg B, et al. Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial[J]. Nature Medicine, 2023: 1-6. |